Instrument Inactif

Autres langues Prosensa Holding NV

Actions

NL0010524443

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

24/11/14	Nouvelle avance du Nyse qui compte sur les banques centrales	RE
24/11/14	NASDAQ COMPOSITE : Wall Street clôture en hausse	RE

Autres langues

30/01/15	Prosensa Announces Intent to Voluntarily Delist From NASDAQ
13/01/15	Prosensa Announces Shareholder Approval of Certain Matters Relating to the BioMarin Tender Offer
27/12/14	Prosensa NV : BioMarin and Prosensa Announce Expiration of the Hart-Scott-Rodino Waiting Period for BioMarin's Proposed Acquisition of Prosensa
04/12/14	Prosensa NV : RNA INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Prosensa Holding N.V. in Connection With the Fairness of the Sale of the Company to BioMarin Pharmaceutical Inc. -- RNA
01/12/14	Prosensa NV : RNA INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Prosensa Holding N.V. in Connection With the Fairness of the Sale of the Company to BioMarin Pharmaceutical Inc. -- RNA
24/11/14	BioMarin Pharmaceutical : S&P 500 ticks up to record on central bank bets
24/11/14	Prosensa NV : RNA INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Prosensa Holding N.V. in Connection With the Fairness of the Sale of the Company to BioMarin Pharmaceutical Inc. -- RNA
24/11/14	BioMarin Pharmaceutical : to buy Prosensa in $840 million deal
12/11/14	Prosensa NV : Cure Duchenne and Prosensa to Present Collaboration at Partnering for Cures Conference
13/10/14	Prosensa NV : start indiening registratiedossier bij FDA voor Duchenne-medicijn drisapersen
26/09/14	Prosensa extends the re-dosing of drisapersen in Europe in patients with Duchenne muscular dystrophy
13/08/14	Prosensa NV : -resultaten tweede kwartaal 2014 en recente ontwikkelingen
06/08/14	Prosensa NV : to Present at the Wedbush 2014 Life Sciences Conference
04/08/14	Prosensa NV : INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Prosensa Holding N.V.
23/07/14	Prosensa NV : INVESTOR ALERT: Class Action Lawsuit Against Prosensa Holding N.V. Announced by Law Offices of Howard G. Smith
21/07/14	Prosensa NV : Holding - National Securities Law Firm Encourages Shareholders to Contact Law Firm Before Lead Plaintiff Deadline
30/06/14	Prosensa NV : versterkt Management Team en Raad van Commissarissen
27/06/14	Prosensa NV : voltooit rekrutering patiënten in natuurlijke beloopstudie
27/06/14	Prosensa Awarded $200,000 Research Grant from PPMD
06/06/14	Prosensa NV : kondigt registratieroute aan voor drisapersen als mogelijk medicijn tegen spierziekte Duchenne
28/05/14	Prosensa to Present at the Jefferies 2014 Global Healthcare Conference
18/03/14	Prosensa NV : jaarresultaten 2013 en recente ontwikkelingen
05/02/14	Prosensa Holding NV : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Prosensa Holding N.V. and Its Disclosures Related to Experimental Drug Drisapersen
16/01/14	Prosensa Reports Initial Findings from the Further Clinical Data Analyses of Drisapersen for the Treatment of Duchenne Muscular Dystrophy
19/12/13	Prosensa Holding NV : Prosensa Comments on Drisapersen Program Update